MASIMO CORP MASI
MASIMO CORP (MASI) earns a Piotroski F-score of 7/9 (strong financial health), with an Altman Z″ in the safe zone. It pays a dividend (safety: no dividend). FY2026 revenue was $1.5B at a -9.9% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
Beneish M-score: -3.64 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
How it ranks in Manufacturing · percentile among 1906 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 7/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.326 |
| Retained earnings / assets | 0.788 |
| EBIT / assets | 0.182 |
| Equity / liabilities | 0.738 |
Sector peers · similar-size Manufacturing companies
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| MASI | MASIMO CORP | 7/9 | 6.71 | — | +9.4% |
| LIVN | LivaNova PLC | 4/9 | 0.72 | — | +10.7% |
| CNMD | CONMED Corp | 5/9 | 2.97 | 23 | +5.2% |
| ITGR | Integer Holdings Corp | 6/9 | 3.52 | 31 | +8% |
| TMDX | TransMedics Group, Inc. | 6/9 | 4.04 | 12.4 | +37.1% |
| AXGN | Axogen, Inc. | 5/9 | -0.43 | — | +20.2% |
| OM | Outset Medical, Inc. | 6/9 | -9.87 | — | +5.1% |
FAQ
Is MASI financially healthy?
MASIMO CORP's Piotroski F-score is 7/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does MASI pay a dividend, and is it safe?
Yes. MASIMO CORP pays a dividend with a None payout ratio, rated “no dividend” for safety.
How profitable is MASI?
In FY2026, MASIMO CORP had a net margin of -9.9% and a return on equity of -21.0%.
Source: SEC EDGAR filings · CIK 0000937556 · US · as of 2026-01-03. facts plus Stocktoria's own computed scores — not investment advice.